West Pharmaceutical Services Inc (WST) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

West Announces Second-Quarter 2024 Results

West Announces Second-Quarter 2024 Results PR Newswire EXTON, Pa., July 25, 2024 - Conference Call Scheduled...

West to Host Second-Quarter 2024 Conference Call

West to Host Second-Quarter 2024 Conference Call PR Newswire EXTON, Pa., July 11, 2024 EXTON, Pa., July 11...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy

West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for...

West to Participate in Upcoming Investor Conference

West to Participate in Upcoming Investor Conference PR Newswire EXTON, Pa., May 28, 2024 EXTON, Pa., May 28...

Form SD - Specialized disclosure report

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities